Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. š§¾ Journal Overview Title: Neurology and Therapy Publisher: Springer Healthcare ISSN: 2193-8231 (print) / 2193-6549 (online) Established: 2012 Access Type: Open Access Indexing: PubMed, Scopus, DOAJ, Embase, Google Scholar Publication Model: Continuous publication (online only) š§ Scope and Aims Neurology and Therapy focuses on clinical research, therapeutic interventions, and real-world studies in neurology. It aims to provide a platform for both original research and practical insights on the management of neurological disorders. Core topics include: Multiple sclerosis Alzheimerās disease and dementias Parkinsonās disease Stroke Epilepsy Neuropathic pain Sleep disorders Neurocritical care Migraine Pharmacological and device-based therapies ā Strengths Therapeutic focus: Unlike broader neurology journals, it emphasizes clinical applicability and treatment strategies, which appeals to neurologists and clinicians looking for real-world relevance. Open access: All articles are freely available, improving visibility and dissemination. Rapid publication: Known for relatively short peer-review and publication cycles, which supports timely dissemination of data. Multiformat content: Includes video abstracts, infographics, and plain language summaries, which enhance accessibility and patient-centered communication. Patient voice inclusion: Occasionally includes patient perspectives, aligning with current trends in participatory medicine. ā ļø Limitations Lack of methodological rigor in some studies: The journal publishes many real-world studies and case series with limited internal validity (small sample sizes, lack of controls, retrospective designs). Not among top-tier neurology journals: It is not considered a leading journal in terms of impact factor, prestige, or citation metrics. Its primary niche is practical, not groundbreaking science. Sponsored content: Some articles are industry-supported or written in collaboration with pharma, requiring the reader to critically assess for bias despite declarations of conflicts of interest. Limited basic science: The journal does not cater to experimental neuroscience or mechanistic studies, making it less attractive to translational researchers. 𩺠Clinical Usefulness Neurology and Therapy is a useful source for up-to-date therapeutic approaches, especially in common neurological diseases where pharmacologic management evolves rapidly. It serves clinicians who value real-world data and pragmatic approaches over purely theoretical or experimental content. However, for systematic reviews, meta-analyses, or guideline-setting research, readers should supplement it with higher-impact journals (e.g., Neurology, Lancet Neurology, Brain). š Ideal Audience General neurologists Pain specialists Clinicians seeking updates in pharmacotherapy Health policy and pharma professionals Residents and trainees exploring applied therapeutics š§ Final Verdict Practical and accessible but methodologically modest. Use it as a source for therapeutic trends and practical updatesānot as a substitute for high-impact evidence. neurology_and_therapy.txt Last modified: 2025/07/14 06:37by administrador